Explore
Validate
LearnABIN395536
antibody from antibodies-online
Targeting: TAC3
LncZBTB39, LncZBTB39-1:2, NK3, NKB, NKNB, ZNEUROK1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN395536 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tachykinin 3 (TAC3) (AA 17-122) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 17-122
- Isotype
- IgG
- Antibody clone number
- 2D7
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Neurokinin B and its receptor in hypogonadotropic hypogonadism.
Common variants of the neuropeptide expressing tachykinin genes and susceptibility to asthma: a case-control study.
TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans.
TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood.
Neurokinin B signaling in puberty: human and animal studies.
Semple RK, Topaloglu AK
Frontiers of hormone research 2010;39:133-41
Frontiers of hormone research 2010;39:133-41
Common variants of the neuropeptide expressing tachykinin genes and susceptibility to asthma: a case-control study.
Klassert TE, Sánchez JJ, Almeida TA, Candenas L, Pinto F, Acosta O, Hernández M
Journal of neuroimmunology 2010 Oct 8;227(1-2):202-7
Journal of neuroimmunology 2010 Oct 8;227(1-2):202-7
TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans.
Young J, Bouligand J, Francou B, Raffin-Sanson ML, Gaillez S, Jeanpierre M, Grynberg M, Kamenicky P, Chanson P, Brailly-Tabard S, Guiochon-Mantel A
The Journal of clinical endocrinology and metabolism 2010 May;95(5):2287-95
The Journal of clinical endocrinology and metabolism 2010 May;95(5):2287-95
TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood.
Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, Abreu AP, Carroll J, Trarbach E, Silveira LF, Costa EM, de Mendonça BB, de Castro M, Lofrano A, Hall JE, Bolu E, Ozata M, Quinton R, Amory JK, Stewart SE, Arlt W, Cole TR, Crowley WF, Kaiser UB, Latronico AC, Seminara SB
The Journal of clinical endocrinology and metabolism 2010 Jun;95(6):2857-67
The Journal of clinical endocrinology and metabolism 2010 Jun;95(6):2857-67
Neurokinin B signaling in puberty: human and animal studies.
Topaloglu AK
Molecular and cellular endocrinology 2010 Aug 5;324(1-2):64-9
Molecular and cellular endocrinology 2010 Aug 5;324(1-2):64-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
